APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ziprasidone Hydrochloride Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ziprasidone Hydrochloride Capsules Industry Growth and Trends Forecast to 2032

28 December 202598 pages

Choose your research edition.

Industry ResearchZiprasidone Hydrochloride Capsules Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Ziprasidone Hydrochloride Capsules Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Ziprasidone Hydrochloride Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ziprasidone Hydrochloride Capsules Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Ziprasidone Hydrochloride Capsules Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Ziprasidone Hydrochloride Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ziprasidone Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ziprasidone Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ziprasidone Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ziprasidone Hydrochloride Capsules include Pfizer, Viatris, Jiangsu Nhwa Pharmaceutical, Lupin Limited, Dr. Reddy's and APOTEX, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ziprasidone Hydrochloride Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ziprasidone Hydrochloride Capsules market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ziprasidone Hydrochloride Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ziprasidone Hydrochloride Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ziprasidone Hydrochloride Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ziprasidone Hydrochloride Capsules Market by Company

Pfizer

Viatris

Jiangsu Nhwa Pharmaceutical

Lupin Limited

Dr. Reddy's

APOTEX

Ziprasidone Hydrochloride Capsules Segment by Type

20mg

40mg

Others

Ziprasidone Hydrochloride Capsules Segment by Application

Hospital and Clinic

Pharmacy

Ziprasidone Hydrochloride Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ziprasidone Hydrochloride Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ziprasidone Hydrochloride Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ziprasidone Hydrochloride Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ziprasidone Hydrochloride Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ziprasidone Hydrochloride Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 20mg Table 2. Major Company of 40mg Table 3. Major Company of Others Table 4. Global Ziprasidone Hydrochloride Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Ziprasidone Hydrochloride Capsules Sales by Type (2021-2026) & (K Units) Table 6. Global Ziprasidone Hydrochloride Capsules Sales Market Share in Volume by Type (2021-2026) Table 7. Global Ziprasidone Hydrochloride Capsules Sales by Type (2021-2026) & (US$ Million) Table 8. Global Ziprasidone Hydrochloride Capsules Sales Market Share in Value by Type (2021-2026) Table 9. Global Ziprasidone Hydrochloride Capsules Price by Type (2021-2026) & (US$/Unit) Table 10. Global Ziprasidone Hydrochloride Capsules Sales by Type (2027-2032) & (K Units) Table 11. Global Ziprasidone Hydrochloride Capsules Sales Market Share in Volume by Type (2027-2032) Table 12. Global Ziprasidone Hydrochloride Capsules Sales by Type (2027-2032) & (US$ Million) Table 13. Global Ziprasidone Hydrochloride Capsules Sales Market Share in Value by Type (2027-2032) Table 14. Global Ziprasidone Hydrochloride Capsules Price by Type (2027-2032) & (US$/Unit) Table 15. North America Ziprasidone Hydrochloride Capsules Sales by Type (2021-2026) & (K Units) Table 16. North America Ziprasidone Hydrochloride Capsules Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Ziprasidone Hydrochloride Capsules Sales by Type (2021-2026) & (K Units) Table 18. Europe Ziprasidone Hydrochloride Capsules Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Ziprasidone Hydrochloride Capsules Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Ziprasidone Hydrochloride Capsules Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Ziprasidone Hydrochloride Capsules Sales by Type (2021-2026) & (K Units) Table 22. Latin America Ziprasidone Hydrochloride Capsules Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Ziprasidone Hydrochloride Capsules Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Ziprasidone Hydrochloride Capsules Sales by Type (2021-2026) & (US$ Million) Table 25. Ziprasidone Hydrochloride Capsules Industry Trends Table 26. Ziprasidone Hydrochloride Capsules Industry Drivers Table 27. Ziprasidone Hydrochloride Capsules Industry Opportunities and Challenges Table 28. Ziprasidone Hydrochloride Capsules Industry Restraints Table 29. Global Ziprasidone Hydrochloride Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Ziprasidone Hydrochloride Capsules Revenue Market Share by Company (2021-2026) Table 31. Global Ziprasidone Hydrochloride Capsules Sales by Company (2021-2026) & (K Units) Table 32. Global Ziprasidone Hydrochloride Capsules Sales Share by Company (2021-2026) Table 33. Global Ziprasidone Hydrochloride Capsules Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Ziprasidone Hydrochloride Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Ziprasidone Hydrochloride Capsules Major Company Production Sites and Headquarters Table 36. Global Ziprasidone Hydrochloride Capsules Company, Product Type & Application Table 37. Global Ziprasidone Hydrochloride Capsules Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Ziprasidone Hydrochloride Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Ziprasidone Hydrochloride Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Ziprasidone Hydrochloride Capsules Sales by Region (2021-2026) & (K Units) Table 42. Global Ziprasidone Hydrochloride Capsules Sales Market Share in Volume by Region (2021-2026) Table 43. Global Ziprasidone Hydrochloride Capsules Sales by Region (2021-2026) & (US$ Million) Table 44. Global Ziprasidone Hydrochloride Capsules Sales Market Share in Value by Region (2021-2026) Table 45. Global Ziprasidone Hydrochloride Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Ziprasidone Hydrochloride Capsules Sales by Region (2027-2032) & (K Units) Table 47. Global Ziprasidone Hydrochloride Capsules Sales Market Share in Volume by Region (2027-2032) Table 48. Global Ziprasidone Hydrochloride Capsules Sales by Region (2027-2032) & (US$ Million) Table 49. Global Ziprasidone Hydrochloride Capsules Sales Market Share in Value by Region (2027-2032) Table 50. Global Ziprasidone Hydrochloride Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Ziprasidone Hydrochloride Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Ziprasidone Hydrochloride Capsules Sales by Application (2021-2026) & (K Units) Table 53. Global Ziprasidone Hydrochloride Capsules Sales Market Share in Volume by Application (2021-2026) Table 54. Global Ziprasidone Hydrochloride Capsules Sales by Application (2021-2026) & (US$ Million) Table 55. Global Ziprasidone Hydrochloride Capsules Sales Market Share in Value by Application (2021-2026) Table 56. Global Ziprasidone Hydrochloride Capsules Price by Application (2021-2026) & (US$/Unit) Table 57. Global Ziprasidone Hydrochloride Capsules Sales by Application (2027-2032) & (K Units) Table 58. Global Ziprasidone Hydrochloride Capsules Sales Market Share in Volume by Application (2027-2032) Table 59. Global Ziprasidone Hydrochloride Capsules Sales by Application (2027-2032) & (US$ Million) Table 60. Global Ziprasidone Hydrochloride Capsules Sales Market Share in Value by Application (2027-2032) Table 61. Global Ziprasidone Hydrochloride Capsules Price by Application (2027-2032) & (US$/Unit) Table 62. North America Ziprasidone Hydrochloride Capsules Sales by Application (2021-2026) & (K Units) Table 63. North America Ziprasidone Hydrochloride Capsules Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Ziprasidone Hydrochloride Capsules Sales by Application (2021-2026) & (K Units) Table 65. Europe Ziprasidone Hydrochloride Capsules Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Ziprasidone Hydrochloride Capsules Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Ziprasidone Hydrochloride Capsules Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Ziprasidone Hydrochloride Capsules Sales by Application (2021-2026) & (K Units) Table 69. Latin America Ziprasidone Hydrochloride Capsules Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Ziprasidone Hydrochloride Capsules Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Ziprasidone Hydrochloride Capsules Sales by Application (2021-2026) & (US$ Million) Table 72. Pfizer Company Information Table 73. Pfizer Business Overview Table 74. Pfizer Ziprasidone Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Pfizer Ziprasidone Hydrochloride Capsules Product Portfolio Table 76. Pfizer Recent Development Table 77. Viatris Company Information Table 78. Viatris Business Overview Table 79. Viatris Ziprasidone Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Viatris Ziprasidone Hydrochloride Capsules Product Portfolio Table 81. Viatris Recent Development Table 82. Jiangsu Nhwa Pharmaceutical Company Information Table 83. Jiangsu Nhwa Pharmaceutical Business Overview Table 84. Jiangsu Nhwa Pharmaceutical Ziprasidone Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Jiangsu Nhwa Pharmaceutical Ziprasidone Hydrochloride Capsules Product Portfolio Table 86. Jiangsu Nhwa Pharmaceutical Recent Development Table 87. Lupin Limited Company Information Table 88. Lupin Limited Business Overview Table 89. Lupin Limited Ziprasidone Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Lupin Limited Ziprasidone Hydrochloride Capsules Product Portfolio Table 91. Lupin Limited Recent Development Table 92. Dr. Reddy's Company Information Table 93. Dr. Reddy's Business Overview Table 94. Dr. Reddy's Ziprasidone Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Dr. Reddy's Ziprasidone Hydrochloride Capsules Product Portfolio Table 96. Dr. Reddy's Recent Development Table 97. APOTEX Company Information Table 98. APOTEX Business Overview Table 99. APOTEX Ziprasidone Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. APOTEX Ziprasidone Hydrochloride Capsules Product Portfolio Table 101. APOTEX Recent Development Table 102. North America Ziprasidone Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. North America Ziprasidone Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 104. North America Ziprasidone Hydrochloride Capsules Sales Market Share by Country (2021-2026) Table 105. North America Ziprasidone Hydrochloride Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 106. North America Ziprasidone Hydrochloride Capsules Sales Market Share Forecast by Country (2027-2032) Table 107. North America Ziprasidone Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. North America Ziprasidone Hydrochloride Capsules Market Size by Country (2021-2026) & (US$ Million) Table 109. North America Ziprasidone Hydrochloride Capsules Market Share by Country (2021-2026) Table 110. North America Ziprasidone Hydrochloride Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. North America Ziprasidone Hydrochloride Capsules Market Share Forecast by Country (2027-2032) Table 112. Europe Ziprasidone Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Europe Ziprasidone Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 114. Europe Ziprasidone Hydrochloride Capsules Sales Market Share by Country (2021-2026) Table 115. Europe Ziprasidone Hydrochloride Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 116. Europe Ziprasidone Hydrochloride Capsules Sales Market Share Forecast by Country (2027-2032) Table 117. Europe Ziprasidone Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Europe Ziprasidone Hydrochloride Capsules Market Size by Country (2021-2026) & (US$ Million) Table 119. Europe Ziprasidone Hydrochloride Capsules Market Share by Country (2021-2026) Table 120. Europe Ziprasidone Hydrochloride Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Europe Ziprasidone Hydrochloride Capsules Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Ziprasidone Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Ziprasidone Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 124. Asia-Pacific Ziprasidone Hydrochloride Capsules Sales Market Share by Country (2021-2026) Table 125. Asia-Pacific Ziprasidone Hydrochloride Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 126. Asia-Pacific Ziprasidone Hydrochloride Capsules Sales Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Ziprasidone Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Ziprasidone Hydrochloride Capsules Market Size by Country (2021-2026) & (US$ Million) Table 129. Asia-Pacific Ziprasidone Hydrochloride Capsules Market Share by Country (2021-2026) Table 130. Asia-Pacific Ziprasidone Hydrochloride Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Asia-Pacific Ziprasidone Hydrochloride Capsules Market Share Forecast by Country (2027-2032) Table 132. Latin America Ziprasidone Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Latin America Ziprasidone Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 134. Latin America Ziprasidone Hydrochloride Capsules Sales Market Share by Country (2021-2026) Table 135. Latin America Ziprasidone Hydrochloride Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 136. Latin America Ziprasidone Hydrochloride Capsules Sales Market Share Forecast by Country (2027-2032) Table 137. Latin America Ziprasidone Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Latin America Ziprasidone Hydrochloride Capsules Market Size by Country (2021-2026) & (US$ Million) Table 139. Latin America Ziprasidone Hydrochloride Capsules Market Share by Country (2021-2026) Table 140. Latin America Ziprasidone Hydrochloride Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Latin America Ziprasidone Hydrochloride Capsules Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Ziprasidone Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Ziprasidone Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 144. Middle East and Africa Ziprasidone Hydrochloride Capsules Sales Market Share by Country (2021-2026) Table 145. Middle East and Africa Ziprasidone Hydrochloride Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 146. Middle East and Africa Ziprasidone Hydrochloride Capsules Sales Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Ziprasidone Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Ziprasidone Hydrochloride Capsules Market Size by Country (2021-2026) & (US$ Million) Table 149. Middle East and Africa Ziprasidone Hydrochloride Capsules Market Share by Country (2021-2026) Table 150. Middle East and Africa Ziprasidone Hydrochloride Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Middle East and Africa Ziprasidone Hydrochloride Capsules Market Share Forecast by Country (2027-2032) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Ziprasidone Hydrochloride Capsules Distributors List Table 155. Ziprasidone Hydrochloride Capsules Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Ziprasidone Hydrochloride Capsules Image Figure 2. Global Ziprasidone Hydrochloride Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ziprasidone Hydrochloride Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Ziprasidone Hydrochloride Capsules Sales (2021-2032) & (K Units) Figure 5. 20mg Image Figure 6. Global 20mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 40mg Image Figure 8. Global 40mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Ziprasidone Hydrochloride Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Ziprasidone Hydrochloride Capsules Market Share by Type 2025 VS 2032 Figure 13. North America Ziprasidone Hydrochloride Capsules Sales Market Share in Volume by Type in 2025 Figure 14. North America Ziprasidone Hydrochloride Capsules Sales Market Share in Value by Type in 2025 Figure 15. Europe Ziprasidone Hydrochloride Capsules Sales Market Share in Volume by Type in 2025 Figure 16. Europe Ziprasidone Hydrochloride Capsules Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Ziprasidone Hydrochloride Capsules Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Ziprasidone Hydrochloride Capsules Sales Market Share in Value by Type in 2025 Figure 19. Latin America Ziprasidone Hydrochloride Capsules Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Ziprasidone Hydrochloride Capsules Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Ziprasidone Hydrochloride Capsules Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Ziprasidone Hydrochloride Capsules Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Ziprasidone Hydrochloride Capsules Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital and Clinic Image Figure 26. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Pharmacy Image Figure 28. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Ziprasidone Hydrochloride Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Ziprasidone Hydrochloride Capsules Market Share by Application 2025 VS 2032 Figure 31. North America Ziprasidone Hydrochloride Capsules Sales Market Share in Volume by Application in 2025 Figure 32. North America Ziprasidone Hydrochloride Capsules Sales Market Share in Value by Application in 2025 Figure 33. Europe Ziprasidone Hydrochloride Capsules Sales Market Share in Volume by Application in 2025 Figure 34. Europe Ziprasidone Hydrochloride Capsules Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Ziprasidone Hydrochloride Capsules Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Ziprasidone Hydrochloride Capsules Sales Market Share in Value by Application in 2025 Figure 37. Latin America Ziprasidone Hydrochloride Capsules Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Ziprasidone Hydrochloride Capsules Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Ziprasidone Hydrochloride Capsules Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Ziprasidone Hydrochloride Capsules Sales Market Share in Value by Application in 2025 Figure 41. North America Ziprasidone Hydrochloride Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Ziprasidone Hydrochloride Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Ziprasidone Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Ziprasidone Hydrochloride Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Ziprasidone Hydrochloride Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Ziprasidone Hydrochloride Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Ziprasidone Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Ziprasidone Hydrochloride Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Ziprasidone Hydrochloride Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Ziprasidone Hydrochloride Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Ziprasidone Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Ziprasidone Hydrochloride Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Ziprasidone Hydrochloride Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Ziprasidone Hydrochloride Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Ziprasidone Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Ziprasidone Hydrochloride Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Ziprasidone Hydrochloride Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Ziprasidone Hydrochloride Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Ziprasidone Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Ziprasidone Hydrochloride Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Ziprasidone Hydrochloride Capsules Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Ziprasidone Hydrochloride Capsules Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 20mg
  • 40mg
  • Others
Applications
  • Hospital and Clinic
  • Pharmacy
Companies covered
  • Pfizer
  • Viatris
  • Jiangsu Nhwa Pharmaceutical
  • Lupin Limited
  • Dr. Reddy's
  • APOTEX

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ziprasidone Hydrochloride Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ziprasidone Hydrochloride Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ziprasidone Hydrochloride Capsules Market by Type
  6. 1.3.1 20mg
  7. 1.3.2 40mg
  8. 1.3.3 Others
  9. 1.4 Global Ziprasidone Hydrochloride Capsules Market Size by Type
  10. 1.4.1 Global Ziprasidone Hydrochloride Capsules Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Ziprasidone Hydrochloride Capsules Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Ziprasidone Hydrochloride Capsules Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Ziprasidone Hydrochloride Capsules Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Ziprasidone Hydrochloride Capsules Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Ziprasidone Hydrochloride Capsules Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Ziprasidone Hydrochloride Capsules Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Ziprasidone Hydrochloride Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ziprasidone Hydrochloride Capsules Industry Trends
  2. 2.2 Ziprasidone Hydrochloride Capsules Industry Drivers
  3. 2.3 Ziprasidone Hydrochloride Capsules Industry Opportunities and Challenges
  4. 2.4 Ziprasidone Hydrochloride Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ziprasidone Hydrochloride Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Ziprasidone Hydrochloride Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Ziprasidone Hydrochloride Capsules Price (2021-2026)
  4. 3.4 Global Ziprasidone Hydrochloride Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ziprasidone Hydrochloride Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Ziprasidone Hydrochloride Capsules Company, Product Type & Application
  7. 3.7 Global Ziprasidone Hydrochloride Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ziprasidone Hydrochloride Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ziprasidone Hydrochloride Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ziprasidone Hydrochloride Capsules Tier 1, Tier 2, and Tier 3
4 Ziprasidone Hydrochloride Capsules Regional Status and Outlook
  1. 4.1 Global Ziprasidone Hydrochloride Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ziprasidone Hydrochloride Capsules Historic Market Size by Region
  3. 4.2.1 Global Ziprasidone Hydrochloride Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ziprasidone Hydrochloride Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ziprasidone Hydrochloride Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ziprasidone Hydrochloride Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Ziprasidone Hydrochloride Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ziprasidone Hydrochloride Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ziprasidone Hydrochloride Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ziprasidone Hydrochloride Capsules by Application
  1. 5.1 Ziprasidone Hydrochloride Capsules Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.2 Global Ziprasidone Hydrochloride Capsules Market Size by Application
  5. 5.2.1 Global Ziprasidone Hydrochloride Capsules Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Ziprasidone Hydrochloride Capsules Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Ziprasidone Hydrochloride Capsules Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Ziprasidone Hydrochloride Capsules Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Ziprasidone Hydrochloride Capsules Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Ziprasidone Hydrochloride Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Ziprasidone Hydrochloride Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Ziprasidone Hydrochloride Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Ziprasidone Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Ziprasidone Hydrochloride Capsules Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 Viatris
  8. 6.2.1 Viatris Company Information
  9. 6.2.2 Viatris Business Overview
  10. 6.2.3 Viatris Ziprasidone Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Viatris Ziprasidone Hydrochloride Capsules Product Portfolio
  12. 6.2.5 Viatris Recent Developments
  13. 6.3 Jiangsu Nhwa Pharmaceutical
  14. 6.3.1 Jiangsu Nhwa Pharmaceutical Company Information
  15. 6.3.2 Jiangsu Nhwa Pharmaceutical Business Overview
  16. 6.3.3 Jiangsu Nhwa Pharmaceutical Ziprasidone Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jiangsu Nhwa Pharmaceutical Ziprasidone Hydrochloride Capsules Product Portfolio
  18. 6.3.5 Jiangsu Nhwa Pharmaceutical Recent Developments
  19. 6.4 Lupin Limited
  20. 6.4.1 Lupin Limited Company Information
  21. 6.4.2 Lupin Limited Business Overview
  22. 6.4.3 Lupin Limited Ziprasidone Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Lupin Limited Ziprasidone Hydrochloride Capsules Product Portfolio
  24. 6.4.5 Lupin Limited Recent Developments
  25. 6.5 Dr. Reddy's
  26. 6.5.1 Dr. Reddy's Company Information
  27. 6.5.2 Dr. Reddy's Business Overview
  28. 6.5.3 Dr. Reddy's Ziprasidone Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Dr. Reddy's Ziprasidone Hydrochloride Capsules Product Portfolio
  30. 6.5.5 Dr. Reddy's Recent Developments
  31. 6.6 APOTEX
  32. 6.6.1 APOTEX Company Information
  33. 6.6.2 APOTEX Business Overview
  34. 6.6.3 APOTEX Ziprasidone Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 APOTEX Ziprasidone Hydrochloride Capsules Product Portfolio
  36. 6.6.5 APOTEX Recent Developments
7 North America by Country
  1. 7.1 North America Ziprasidone Hydrochloride Capsules Sales by Country
  2. 7.1.1 North America Ziprasidone Hydrochloride Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ziprasidone Hydrochloride Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Ziprasidone Hydrochloride Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ziprasidone Hydrochloride Capsules Market Size by Country
  6. 7.2.1 North America Ziprasidone Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ziprasidone Hydrochloride Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Ziprasidone Hydrochloride Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ziprasidone Hydrochloride Capsules Sales by Country
  2. 8.1.1 Europe Ziprasidone Hydrochloride Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ziprasidone Hydrochloride Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Ziprasidone Hydrochloride Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ziprasidone Hydrochloride Capsules Market Size by Country
  6. 8.2.1 Europe Ziprasidone Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ziprasidone Hydrochloride Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ziprasidone Hydrochloride Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ziprasidone Hydrochloride Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Ziprasidone Hydrochloride Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ziprasidone Hydrochloride Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ziprasidone Hydrochloride Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ziprasidone Hydrochloride Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Ziprasidone Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ziprasidone Hydrochloride Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ziprasidone Hydrochloride Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ziprasidone Hydrochloride Capsules Sales by Country
  2. 10.1.1 South America Ziprasidone Hydrochloride Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ziprasidone Hydrochloride Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Ziprasidone Hydrochloride Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ziprasidone Hydrochloride Capsules Market Size by Country
  6. 10.2.1 South America Ziprasidone Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ziprasidone Hydrochloride Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Ziprasidone Hydrochloride Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ziprasidone Hydrochloride Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Ziprasidone Hydrochloride Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ziprasidone Hydrochloride Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ziprasidone Hydrochloride Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ziprasidone Hydrochloride Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Ziprasidone Hydrochloride Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ziprasidone Hydrochloride Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ziprasidone Hydrochloride Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ziprasidone Hydrochloride Capsules Value Chain Analysis
  2. 12.1.1 Ziprasidone Hydrochloride Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ziprasidone Hydrochloride Capsules Production Mode & Process
  7. 12.2 Ziprasidone Hydrochloride Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ziprasidone Hydrochloride Capsules Distributors
  10. 12.2.3 Ziprasidone Hydrochloride Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst